The FDA has granted breakthrough therapy designation to privosegtor for optic neuritis, a common symptom of multiple sclerosis.
To compare both retinal nerve fiber layer thickness and orbital color Doppler ultrasonography parameters in patients with multiple sclerosis (MS) versus healthy controls. The studied eyes exposed ...
Please provide your email address to receive an email when new articles are posted on . Dr. Golnik: My pleasure. Dr. Hovanesian: We are going to talk about optic neuritis, with emphasis on new ...
A 71-year-old man was referred by his usual ophthalmologist to the neuro-ophthalmology clinic at Tufts Medical Center for bilateral decreased vision associated with bilateral optic disc edema. His ...
To investigate, by focal macular electroretinography (ERG), the change of photopic negative response (PhNR) in the recovery of visual function in patients with optic neuritis. Focal macular ERG was ...
OCS-05 demonstrates safety and efficacy in treating acute optic neuritis, receiving FDA IND clearance for clinical development in the U.S. Small sample size of only 36 patients in the Phase 2 ACUITY ...
Privosegtor is advancing in the registrational PIONEER program across 2 key optic neuropathies, representing an unaddressed potential market of $7 billion in the U.S. Privosegtor achieved an average ...
Ophthalmologists, optometrists, and neurologists may be widely overdiagnosing optic neuritis, researchers say. Neuro-ophthalmologists at Washington University in St Louis, Missouri, could confirm only ...
MS can impact your vision in various ways. It can make your vision hazy or give you double vision. It can also cause your eyes to move involuntarily. In some cases, it can even lead to blindness.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results